Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Excelestar Ventures LLC is a venture capital firm founded in 2009 and headquartered in Andover, Massachusetts. The firm specializes in investing in B2B companies, particularly within the technology and medical device sectors. Excelestar Ventures is notable for its commitment to supporting underrepresented founders, with a significant portion of its portfolio consisting of minority-led and female-led companies. This focus on diversity is a core aspect of the firm's investment philosophy.
As of now, Excelestar Ventures manages a portfolio of 21 companies, demonstrating a strong track record in identifying and nurturing innovative startups. The firm emphasizes the importance of strong leadership and market readiness, ensuring that its investments align with potential growth opportunities. Excelestar Ventures has established itself as a key player in the venture capital landscape, particularly in the United States, where it actively seeks to invest in disruptive technologies.
Excelestar Ventures invests in companies that exhibit clear, disruptive technology, particularly in the fields of medical technology, software as a service (SaaS), artificial intelligence (AI), fintech, and biotechnology. The firm targets early-stage investments, including pre-seed, seed, Series A, and Series B rounds, with a flexible approach to check sizes based on the specific needs of each company. Excelestar Ventures is particularly interested in B2B companies that demonstrate strong teams and innovative solutions.
The firm conducts thorough market research, primary interviews, and detailed analysis to ensure alignment with market readiness and company potential. Excelestar Ventures is open to investing off-thesis if the founding team is impressive, highlighting its commitment to identifying exceptional talent. This investment strategy is complemented by a collaborative partner model, where active mentorship is provided to portfolio companies, fostering an environment conducive to growth and success.
Excelestar Ventures has a diverse portfolio of 21 companies, with notable investments including:
Other portfolio companies include Conformal Medical, Datacy, Neurolutions, Terecircuits, and Sealonix, among others. Excelestar Ventures has successfully facilitated notable exits, including Augmenix and nVision, both acquired by Boston Scientific.
Tasneem Dohadwala - Founding Partner; prior experience includes Lehman Brothers and Matrix Partners. Tasneem holds an MBA from Harvard Business School and is also the Managing Director of Golden Seeds. She has been recognized as "Investor of the Year" by Startup Boston for her contributions to the venture capital community.
Emily Giudice - Principal; Emily has a background in operations at venture-backed and public digital health companies. She earned her MBA from MIT Sloan, focusing on healthcare, and brings valuable insights into the healthcare technology sector.
To pitch Excelestar Ventures, founders should visit their website at excelestarventures.com. It is advisable to include a comprehensive pitch deck that outlines the business model, market opportunity, competitive landscape, and team background. The firm appreciates clear and concise presentations that highlight the startup's unique value proposition.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are preferred, but cold outreach is also accepted.
In October 2025, Excelestar Ventures announced that Instylla successfully raised Series B-III funding, further solidifying its position in the medical device market. The firm continues to update its portfolio with a focus on underrepresented founders, maintaining its commitment to diversity and innovation.
Excelestar Ventures has also been recognized for its efforts in supporting minority-led and female-led companies, with 61% of its portfolio consisting of minority-led startups and 50% female-led startups. This commitment to diversity has positioned the firm as a leader in promoting inclusive investment practices.
What are Excelestar Ventures' investment criteria?
Excelestar Ventures focuses on B2B companies with disruptive technology, particularly in the technology and medical device sectors. The firm seeks strong founding teams and is open to investing off-thesis if the team demonstrates exceptional potential.
How can I pitch to Excelestar Ventures?
Founders can pitch Excelestar Ventures through their website at excelestarventures.com. It is recommended to include a clear overview of the business model, market opportunity, and team qualifications in the pitch deck.
What makes Excelestar Ventures different from other VC firms?
Excelestar Ventures is distinguished by its commitment to supporting underrepresented founders, with 61% of its portfolio being minority-led and 50% female-led. This focus on diversity is integral to their investment philosophy.
What is the geographic focus of Excelestar Ventures?
The firm primarily invests in companies based in the United States, with a particular emphasis on those located in Massachusetts.
What is the typical check size for investments?
Excelestar Ventures employs a flexible approach to check sizes, tailoring investments to the specific needs of each company and the stage of development.
What kind of support do portfolio companies receive?
Excelestar Ventures provides active mentorship and a collaborative partner model, ensuring that portfolio companies receive guidance on leadership, market readiness, and growth strategies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.